Herpes Zoster in the Long-Term Care Setting

Annals of Long-Term Care

Volumn 12, Issue 1, 2004, Pages 38-42

  Schmader, Kenneth ^a  

^a DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CHICKENPOX VACCINE; DESIPRAMINE; FAMCICLOVIR; GABAPENTIN; HERPES ZOSTER IMMUNOGLOBULIN; LIDOCAINE; NORTRIPTYLINE; VALACICLOVIR;

ANTICHOLINERGIC EFFECT; ATAXIA; COGNITIVE DEFECT; CONSTIPATION; DIARRHEA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DOSE RESPONSE; DYSPEPSIA; EDEMA; GASTROINTESTINAL SYMPTOM; GRANULOCYTOSIS; HEADACHE; HERPES ZOSTER; HUMAN; IMMUNIZATION; INFECTION CONTROL; LONG TERM CARE; NAUSEA; ORTHOSTATIC HYPOTENSION; PAIN; POSTHERPETIC NEURALGIA; RASH; REVIEW; SEDATION; SENSORY GANGLION; SEROLOGY; SOMNOLENCE; VARICELLA ZOSTER VIRUS; VERTIGO; VOMITING;

EID: 0347635348     PISSN: 15247929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Hope-Simpson RE. The nature of herpes zoster: A long-term study and new hypothesis. Proc R Soc Med 1965;58:9-20.
2. Schmader K, George LK, Burchett BM, et al. Racial differences in the occurrence of herpes zoster. J Infect Dis 1995;171(3):701-704.
3. Schmader K, George LK, Burchett BM, et al. Race and stress in the incidence of herpes zoster in older adults. J Am Geriatr Soc 1998;46(8):973-977.
4. Chao PW, Galil K, Donahue JG, et al. Risk factors for postherpetic neuralgia. Arch Intern Med 1997;157(11):1217-1224.
5. Dworkin RH, Schmader KE. The Epidemiology and Natural History of Herpes Zoster and Postherpetic Neuralgia. In: Watson CPN, ed. Herpes Zoster and Postherpetic Neuralgia. Amsterdam, Netherlands: Elsevier Science; 2001:39-65.
6. Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zaster: Prospective study with long term follow up; BMJ 2000;321(7264):794-796.
7. Schmader KE. Herpes Zoster. In: Cassel CK, et al, eds. Geriatric Medicine, 4th Ed. New York, NY: Springer-Verlag; 2003:1043-1057.
8. Schmader, KE. Herpes Zoster Epidemiology. In: Arvin A, Gershon A, eds. Varicella-Zoster Virus. Virology and Clinical Management. Cambridge, MA: Cambridge University Press; 2000:220-246.
9. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: A case-control study Lancet 2002;360:678-682.
10. Saiman L, Weber DJ. Prevention of nosocomial transmission. In: Arvin A, Gershon A, eds. Varicella-Zoster Virus. Virology and Clinical Management. Cambridge, MA: Cambridge University Press; 2000:477-499.
11. Garner JS. Guideline for isolation precaution in hospitals. The Hospital Infection Control Pratices Advisory Committee. Infect Control Hosp Epidemiol 1996;17(1):53-80.
12. Centers for Disease Control. Prevention of varicella: Updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morbidity and Mortality Weekly Report 1999;48(RR-6):1-5.
13. Annunziato PW, Gershon AA. Primary immunization against varicella. In: Arvin A, Gershon A, eds. Varicella-Zoster Virus. Virology and Clinical Management. Cambridge, MA: Cambridge University Press; 2000:460-477.
14. Levin MJ, Barber D, Goldblatt E, et al. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis 1998;178(suppl 1): S109-S112.
15. Kost RG, Straus SE. Postherpetic neuralgia-pathogenesis, treatment, and prevention. N Engl J Med 1996;335(1):32-42.
16. Wood MJ, Johnson RW, McKendrick MW, et al. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994;330(13):896-900.
17. Whitley RJ, Weiss H, Gnann JW, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996;125(5):376-383.
18. AGS panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002;50(6 suppl):S205-S224.
19. Dworkin RH, Schmader KE. Treatment and prevention of postherpetic neuralgia. Clin Infect Dis 2003;36(7):877-882.
20. Watson CPN, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial. Neurology 1998;51(4):1166-1171.
21. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 1998;50(6):1837-1841.
22. Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: Results of an enriched enrollment study. Pain 1999;80(3):533-538.
23. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of pastherpetic neuralgia: An randomized controlled trial. JAMA 1998;280(1):1837-1842.